Insight Molecular Diagnostics (IMDX) Long-Term Investments (2019 - 2020)
Insight Molecular Diagnostics (IMDX) posted Long-Term Investments of $13.4 million for Q4 2020, down 3.14% sequentially from $13.9 million in Q3 2020, and up 22.37% YoY from $11.0 million in Q1 2020.
Insight Molecular Diagnostics (IMDX) Long-Term Investments (2019 - 2020) Analysis & Trends
Insight Molecular Diagnostics has reported Long-Term Investments for 2 years, with the latest figure at $13.4 million in Q4 2020.
- Quarterly Long-Term Investments rose 22.37% year-over-year to $13.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $13.4 million (up 22.37% YoY) and the FY2020 annual result came in at $13.4 million, up 22.37% from the prior year.
- Long-Term Investments declined to $13.4 million in Q4 2020 per IMDX's latest filing, from $13.9 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $14.3 million in Q2 2020 and troughed at $10.6 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 136.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 390.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 210.00 Mn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 13.42 Mn |
| Sep 30, 2020 | 13.85 Mn |
| Jun 30, 2020 | 14.33 Mn |
| Mar 31, 2020 | 10.64 Mn |
| Dec 31, 2019 | 10.96 Mn |
| Sep 30, 2019 | 11.25 Mn |